Archit Organosys Q1 Results Board Meet on Aug 12, 2026

What the company has announced

Archit Organosys Limited has scheduled a board meeting on Wednesday, August 12, 2026, to consider and approve its unaudited financial results for the quarter ended June 30, 2026. The update was shared through a filing with BSE Limited. For shareholders and market participants, the date is important because it is the formal point when the company’s June-quarter performance will be placed before the board and then made available to the market.

The latest corporate calendar also includes dividend-related dates and the company’s annual general meeting (AGM) schedule. Separately, the company has disclosed changes to items that were originally part of the AGM agenda, citing pending in-principle approval from the stock exchange for a proposed preferential issue.

Board meeting on August 12 for June-quarter results

According to the BSE filing referenced in the disclosure, the board will meet on August 12, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026. This is the first quarter of the financial year for companies that follow the April to March financial year cycle.

The disclosure is specific to the purpose of the meeting: approval of unaudited quarterly results. No additional financial metrics were included in the provided information, and the company has not, in the same context, provided revenue, profit, or margin figures.

Trading window closure for insiders

Archit Organosys said the trading window for promoters, directors, senior managerial personnel, and connected persons has been closed from July 1, 2026. The window will reopen 48 hours after the results become generally available.

Trading window restrictions are commonly used to manage unpublished price-sensitive information around results and other major corporate events. In this case, the company has linked the reopening timeline explicitly to the availability of the quarterly results.

AGM set for September 30, 2026 via video conferencing

The company will hold its 33rd AGM on Wednesday, September 30, 2026, at 1:30 pm. The meeting will be conducted through video conferencing or other audio-visual means (VC/OAVM), as per the details provided.

Archit Organosys has also outlined the remote e-voting window for shareholders, which will run for three days ahead of the AGM. The company has appointed National Securities Depository Limited (NSDL) as the authorized agency for remote e-voting.

E-voting window and shareholder participation process

Remote e-voting is scheduled to start on September 27, 2026 at 10:00 am and end on September 29, 2026 at 5:00 pm. The company has stated that shareholders who vote remotely cannot vote again during the AGM.

For shareholders holding shares in physical form, the company has provided an email process to request login credentials by writing to share@architorg.com with name, folio number, PAN, and Aadhaar card copies. Demat holders can request credentials through their depository participants or by emailing evoting@nsdl.co.in.

Dividend record date and share transfer book closure

The record date for determining dividend entitlements has been set as Wednesday, September 23, 2026. The company has also stated that the share transfer books will remain closed from September 24, 2026 to September 29, 2026 (inclusive).

In the same information set, Archit Organosys is shown as having announced a cash dividend of INR 1.00 per share with an ex-date of September 23, 2026.

Preferential issue agenda items withdrawn to restructure the proposal

In a separate recent event dated September 23, 2026, Archit Organosys disclosed that it withdrew three items from the agenda of its AGM scheduled for September 30. The withdrawn agenda items related to:

• an increase in authorised share capital
• acquisition of 1,36,24,172 equity shares of Archit Life Science
• a preferential allotment of equity for consideration other than cash

The board said an application for in-principal approval of the preferential issue was pending with BSE, and the proposals were being withdrawn in their present form to restructure the transaction.

Snapshot of the stock and identifiers shown

The provided market snapshot lists Archit Organosys Limited as ARCHITORG.BO and shows a price of ₹64.89, down ₹0.79 (1.20%) at the time of the displayed close. The same context also references dividend information and corporate filings.

Investors typically track such disclosures together because they shape the near-term flow of company updates: quarterly results, dividend timelines, and governance items placed before shareholders.

Key dates at a glance

Company location details cited in the information

The information provided includes office and correspondence addresses and contact details, including a Mumbai address at Bandra Kurla Complex, and a correspondence address at Infinity IT Park, Malad (East), Mumbai. An address in Ahmedabad, Gujarat (9th Floor, Venus Benecia, Near Pakwan Restaurant, Ahmedabad 380054) is also shown under company details.

Why these disclosures matter for investors

The August 12 board meeting sets the point when Archit Organosys’ June-quarter numbers will be formally approved and released. The trading window closure timeline clarifies when insiders and connected persons are restricted from trading, and when that restriction is expected to lift.

The AGM timetable, dividend record date, and book closure dates matter operationally for shareholders who are planning participation and tracking entitlement timelines. Separately, the withdrawal of preferential issue-related proposals indicates that parts of the capital and transaction structure, as previously drafted for shareholder consideration, are being revisited in the current form due to the pending in-principle approval process mentioned by the board.

Conclusion

Archit Organosys has lined up a results-focused board meeting on August 12, 2026, with a trading window closure in place from July 1 until 48 hours after the results are generally available. In the weeks after, the company’s corporate calendar includes the dividend record date on September 23, share transfer book closure from September 24-29, and its 33rd AGM on September 30 via VC/OAVM. The company has also withdrawn certain preferential issue and related proposals from the AGM agenda, stating that the transaction is being restructured while in-principle approval remains pending with BSE.